$0.0001
0[0.00%]
Last update: 9:31AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / - | Mkt Cap1.137K |
| Day Range- - - | 52 Wk Range0.000 - 0.020 |
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%
BG Medicine Stock (OTC:BGMD), Key Statistics
BG Medicine Stock (OTC: BGMD) analysis, key statistics.
Valuation Measures
Enterprise Value
567.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.1M
Total Assets
2.1M
Total Liabilities
4.1M
Profitability
Net income Growth
- -
Gross Margin
71.72%
Net Margin
-328.62%
EBIT Margin
-311.03%
EBITDA Margin
-304.83%
Operating Margin
-311.03%